Current Concepts in the Treatment of Renovascular Hypertension

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Renovascular disease (RVD) remains a major cause of secondary and treatment-resistant hypertension. Most cases are related either to fibromuscular or atherosclerotic lesions, but a variety of other causes including arterial dissection, stent occlusion, and embolic disease can produce the same syndrome. Recent studies emphasize the kidney's tolerance to moderate flow reduction during antihypertensive drug therapy and the relative safety of medical therapy to control blood pressure. Several prospective trials in moderate RVD fail to identify major benefits from endovascular revascularization for moderate atherosclerotic disease. However, high-risk and progressive renovascular syndromes are recognized to be relatively refractory to medical therapy only and respond better to combining renal revascularization with ongoing medical therapy. Clinicians caring for complex hypertension should be familiar with pathogenic pathways, imaging techniques, and a rational approach to managing renovascular hypertension in the current era.

Original languageEnglish (US)
Pages (from-to)139-149
Number of pages11
JournalAmerican journal of hypertension
Issue number2
StatePublished - Feb 1 2018


  • blood pressure
  • hypertension
  • ischemic nephropathy
  • kidney
  • renal artery stenosis
  • renovascular hypertension
  • stenting

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Current Concepts in the Treatment of Renovascular Hypertension'. Together they form a unique fingerprint.

Cite this